Stock listing
4d Molecular Therapeutics, Inc.
Selected listing: FDMT · NASDAQ · USD · US
4d Molecular Therapeutics, Inc. (NASDAQ:FDMT), Health Technology. Latest release Oct 5, 2026: 4DMT to Host Investor Day on October 21, 2026.
- Ticker
- NASDAQ:FDMT
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About 4d Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. (ticker: FDMT) is a public company based in the United States, specializing in innovative gene therapies. 4D Molecular Therapeutics is committed to improving patient outcomes through its research and development efforts.
Latest news from 4d Molecular Therapeutics, Inc.
4DMT to Host Investor Day on October 21, 2026
October 4, 2026
4DMT to Host Investor Day on October 21, 2026
October 5, 2026
4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME
September 28, 2026
4DMT Reports Second Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones
August 13, 2026
4DMT Announces Positive 2-Year Data from PRISM Phase 2b Clinical Trial in a Broad Wet AMD Population
July 18, 2026
Research 4d Molecular Therapeutics, Inc.
4d Molecular Therapeutics, Inc. company profile
View the public company page for 4d Molecular Therapeutics, Inc. on 6ix.
4d Molecular Therapeutics, Inc. news
Read company news and market updates connected to 4d Molecular Therapeutics, Inc..
4d Molecular Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for 4d Molecular Therapeutics, Inc..